CELLTOLERANCE
LIVE

Serial Number

79408132

Owner

MAUNA KEA TECHNOLOGIES

Attorney

Jeff Goehring

Filing Date

Jul 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CELLTOLERANCE Trademark

Serial Number: 79408132 • Registration: 8268362

CELLTOLERANCE is a trademark filed by MAUNA KEA TECHNOLOGIES on July 22, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MAUNA KEA TECHNOLOGIES (3 trademarks)

9 rue d'Enghien

Entity Type: 33

Trademark Details

Filing Date

July 22, 2024

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Health care services for human beings, namely gastrointestinal health care services; medical analysis services relating to the treatment of patients; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collection, treatment and processing of human cells; medical assessment of health status for medical diagnostic purposes; medical diagnosis services, namely, medical diagnosis of digestive disorders; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medical testing services for diagnostic or treatment purposes; health care management in the nature of developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in the field of gastroenterology; individual medical advisory services provided to patients; medical testing services for the diagnosis and treatment of persons

Scientific and technological services, namely, scientific research and design services in the field of diagnostic tools for medical applications; Development of new technology on behalf of third parties in the field of biotechnology; providing information relating to medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; scientific research and development in the field of pharmaceuticals and biotechnology; analyzing, assessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patient, to assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Apr 2, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 18, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 22, 2025 GNFN
FINAL REFUSAL E-MAILED
Aug 22, 2025 GNFR
FINAL REFUSAL WRITTEN
Aug 22, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 4, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 16, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 15, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2024 REPR